HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers.

Abstract
Reduced door-to-balloon time in primary percutaneous coronary intervention for the treatment of ST-elevation myocardial infarction has been associated with lower cardiac mortality rates. However, it remains unclear whether door-to-balloon time is predominantly a surrogate for overall peri-myocardial infarction care and is not independently predictive of outcomes, particularly when differences in door-to-balloon time have narrowed and previous studies have contained myocardial infarction-selection bias.We analyzed 179 consecutive patients who presented emergently at our cardiac catheterization laboratory with ST-elevation myocardial infarction within 12 hours of symptom onset and who underwent primary percutaneous coronary intervention within 3 hours of presentation. Our curve estimation regression model used the natural logarithm (ln) of area under the curve (AUC) of creatine kinase to evaluate the effect of door-to-balloon time on cardiac biomarker levels. We correlated ln (AUC-creatine kinase) with improvement of left ventricular ejection fraction at follow-up and with the intermediate-term mortality rate.Median door-to-balloon time was 87 minutes (interquartile range, 65-113 min). The ln (AUC-creatine kinase) correlated significantly with door-to-balloon time (r=0.2, P=0.02). Upon propensity-score analysis, door-to-balloon time remained a significant independent predictor of ln (AUC-creatine kinase) (beta=0.15, P=0.03). Upon use of a Cox regression model, ln (AUC-creatine kinase) independently predicted death (P=0.04) and recovery of left ventricular function (P=0.001) at follow-up (mean, 14 mo).Longer door-to-balloon time independently predicts increased myocardial cell damage, and ln (AUC-creatine kinase) predicts improvement in left ventricular systolic function and intermediate-term death after ST-elevation myocardial infarction.
AuthorsRobert M Minutello, Luke Kim, Smita Aggarwal, Linda J Cuomo, Dmitriy N Feldman, S Chiu Wong
JournalTexas Heart Institute journal (Tex Heart Inst J) Vol. 37 Issue 2 Pg. 161-5 ( 2010) ISSN: 1526-6702 [Electronic] United States
PMID20401287 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Creatine Kinase
Topics
  • Aged
  • Angioplasty, Balloon, Coronary (adverse effects, mortality)
  • Area Under Curve
  • Biomarkers (blood)
  • Creatine Kinase (blood)
  • Female
  • Health Services Accessibility
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, drug therapy, mortality, pathology, physiopathology)
  • Myocardium (enzymology, pathology)
  • Necrosis
  • Propensity Score
  • Proportional Hazards Models
  • Quality Indicators, Health Care
  • Recovery of Function
  • Registries
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: